investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

EGFR T790M-mediated drug resistance in non-small cell lung cancer

Pinar Ozden Eser

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Pinar Ozden Eser

Harvard University

Cambridge, United States

Related projects

Mark G. Kris

Targets for Therapy for Carcinomas of the Lung

Trachea, bronchus and lung

Stefan Posse

Early Detection of Response to Treatment in Cancer by Hyperpolarized Metabolic MR

Trachea, bronchus and lung

Pathology

Pasi A Janne

Drug Resistance in Lung Cancer

Trachea, bronchus and lung

Pasi A Janne

Targeting RET in Lung Cancer

Trachea, bronchus and lung

Pathology

Christopher S Garris

The Role of Driver Mutations in Lung Cancer Response to Anti-PD-1 Therapy

Trachea, bronchus and lung

Philip N Tsichlis

The role of IWS1 in development and tumorigenesis

Trachea, bronchus and lung

Giovanna Tosato

Angiogenesis and Tumor Growth

Trachea, bronchus and lung

Ji Ming Wang

Role of Formylpeptide Receptors in Host Defense

Trachea, bronchus and lung

Amato J Giaccia

Tumor Hypoxia: Molecular Studies and Clinical Exploitation

Trachea, bronchus and lung

Radiation Oncology